Skip to content

Clinical trials

Phase 1/2 Substance-Related Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 1/2 Country / region: United States Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20045
20063
20072
20082
20095
20106
20115
20122
20131
20141
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Unknown status3
Withdrawn3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of South Carolina5
Boston Children's Hospital3
Treatment Research Institute3
Yale University3
George Mason University2
University of California, San Francisco2
Virginia Commonwealth University2
Wayne State University2
Baylor College of Medicine1
Boston Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders41
Alcoholism5
Opioid-Related Disorders4
Stress Disorders, Post-Traumatic4
Acquired Immunodeficiency Syndrome3
Cocaine-Related Disorders2
Marijuana Abuse2
Tobacco Use Disorder2
Amphetamine-Related Disorders1
Anxiety Disorders1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.